期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

凝血/纤溶系统与SIRS、Sepsis 被引量：4

下载PDF
导出
摘要 凝血/纤溶系统功能紊乱在全身性感染(Sepsis)的发生发展中有着重要作用,本文综述凝血/纤溶系统功能紊乱与Sepsis的关系、三种重要抗凝因子(抗凝血酶Ⅲ,活化蛋白C、组织因子途径抑制剂)的作用及其在Sepsis中的应用。
作者 詹芝娅
机构地区 台州学院医学院外科教研室
出处 《黑龙江医药》 CAS 2008年第5期69-71,共3页 Heilongjiang Medicine journal
关键词 全身性炎症反应综合征 凝血/纤溶系统功能紊乱 抗凝血因子
分类号 R96 [医药卫生—药理学] R6 [医药卫生—外科学]
  • 相关文献

参考文献16

  • 1程尉新,林洪远,盛志勇.凝血系统紊乱在多器官功能不全综合征发病中的作用[J].中国危重病急救医学,2000,12(10):632-635. 被引量：63
  • 2Creasey AA, Chang AC, Feigen L, et al.Tissue factor pathway inhibitor reduces mortality from eschericia coli septic shock[J] . J Clin Invest, 1993, 91:2850 - 2860.
  • 3de Jonge E, Dekkers PE, Creasey AA, et al.Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia [J]. Blood, 2000, 95:1124 - 1129.
  • 4Opal SM, Palardy JE, Parejo NA, et al.The activity of tissue factor pathway inhibitor in experimental models of superantigen- induced shock and polymicrobial intra-abdominal sepsis[J]. Crit Care Med, 2001,29:13 - 17.
  • 5Mammen EF.Antithrombin: its physiological importance and role in DIC[J]. Semin Thromb Hemost, 1998, 24:19 - 25.
  • 6Harada N, Ckajima K, Kushimoto S, et al .Antithrombin, reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin [J]. Blood, 1999, 93:157 - 164.
  • 7Uchiha M, Okajima K.Antithrombin Ⅲ (ATⅢ)prevents LPSinduced pulmonary vascular injury: novel biological activity of AT Ⅲ [J] . Sexton Thromb Hermost, 1997, 23:583 - 590.
  • 8Totzke G, Schobersberger W, Schloesser M, et al.Effects of anfithrombin Ⅲ on tumor necrosis factor-alpha and interleukin -lbeta synthesis in vascular smooth muscle cells[J] .J Interferon Cytokine Res, 2001, 21:1063 - 1069.
  • 9DePalo V,Kessler C,Opal SM.Success or failure in phase Ⅲ sepsis trials:comparisons between the Drotecogin alfa(activated )and antithrombin Ⅲ clinical trials[J].A dv Sepsisl,2001,290:238-247.
  • 10Ramasamy S, Lipke DW, McClain CJ, et al.Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells [J] .J Cell Physiol, 1995, 162:119 - 126.

二级参考文献2

  • 1Kessler C，Blood，1997年，89卷，4393页
  • 2Creasey A A，J Clin Invest，1993年，91卷，2850页

共引文献62

同被引文献29

  • 1吴元锋,郑裕国.微生物法生产维生素K_2(MK)[J].科技通报,2004,20(5):428-433. 被引量：13
  • 2沙长青,杨志兴,赵长山.纳豆芽孢杆菌发酵生产维生素K_2的生物合成途径及其基因调控[J].生物技术,2004,14(5):55-57. 被引量：7
  • 3Bone RC, BallkRA, Cerra FB, et al. Definition for sepsis and organ failure and guideline for the use of innovative therapies in sepsis [J]. Chest, 1992, 101 (6): 1644-1655.
  • 4Naworth PP, Stern DM. Modulation of endothelial cell hemo- static properties by tumor mecrosis factor [J]. J Exp Med, 1986, 163 (3): 740.
  • 5宁勇;夏薇;欧阳丹明.血液学检验[M]北京:高等教育出版社,2010255.
  • 6沙长青,杨志兴,赵长山.维生素K2的合成方法研究[D].[硕士学位论文]:重庆:重庆大学,2012.
  • 7Huang Z B, Wan S L, Lu Y J, et al. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmeno- pausal women: a meta-analysis of randomized controlled trials [J]. Osteoporosis International, 2015, 26 (3): 1175-1186.
  • 8Leon J S, Kirsten J F T, Karly H, et al. Vitamin K-containing di- etary supplements: comparison of synthetic vitamin K1 and nat-to-derived menaquinone-7[J]. Blood, 2007, 109: 3279-3283.
  • 9Shiraishi E, Iijima H, Shinzaki S, et al. Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis[J]. J Gastroenterol, 2016, 51 (4): 346-356.
  • 10Kamali F, Wood P, Ward A. Vitamin K deficiency amplifies an- ticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety[J]. Ann Hematol, 2009, 88 (2): 141-149.

引证文献4

二级引证文献10

黑龙江医药
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部